Join me at PER's "Medical Crossfire®: Radiation and Medical Oncology Assess Immuno-Oncology Strategies in Stage III NSCLC" live, interactive webcast on April 29 to discuss where the management of stage III NSCLC is headed. Register now: bit.ly/2PjIv1p Yale School of Medicine